Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M. Spänig
Observed names:
M. Spaenig,
Max Spaenig,
Max Spänig,
Spänig, Max
Institutions:
University of Veterinary Medicine Hannover, Foundation,
Fraunhofer Institute for Toxicology and Experimental Medicine
Observed institutions:
University of Veterinary Medicine Hannover, Foundation,
Fraunhofer Institute for Toxicology and Experimental Medicine
ORCID:
0009-0002-9463-9421
Observed ORCID:
0009-0002-9463-9421
OpenAlex ID:
A5092764362
Extrapolation of in vitro effect concentrations to in vivo bioavailable concentrations using PBK modelling in humans for two classes of persistent and mobile compounds: triazoles and triazines
2026
·
Abishek Laxmanan Ravi Shankar
, Jenny Irwan
, et al.
·
Archives of Toxicology
·
3
PDF
Estimation of bioavailable concentration of endogenously formed N-nitrosamines by physiologically based kinetic modelling
2025
·
Max Spaenig
, Matthias Vogel
, et al.
·
ALTEX
·
3
PDF
NAMs for closing knowledge gaps in assessment of respiratory uptake – a PARC project
2026
·
Pierre-André Billat
, Tanja Hansen
, et al.
·
Frontiers in Toxicology
·
2
PDF
Applicability of next-generation risk assessment generic PBK models and their performance within the chemical domain
2026
·
M. Spaenig
, M. W. Ashraf
, et al.
·
Archives of Toxicology
·
1
PDF
211 How to use reverse dosimetry to derive acceptable occupational exposure level from internal values
2024
·
Stefan Hahn
, Max Spänig
, et al.
·
Annals of Work Exposures and Health
·
1
PDF
Final report on training Lot 2 Trainings on horizontal scientific assessment methodologies OC/EFSA/KNOW/2022/01 ‐ LOT 2
2026
·
Sylvia E. Escher
, Monika Batke
, et al.
·
EFSA Supporting Publications
PDF
NAMs for closing knowledge gaps in assessment of respiratory uptake - a PARC project
2026
·
Billat, Pierre-André
, Hansen, Tanja
, et al.
·
Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Estimation of bioavailable concentration of endogenously formed N-nitrosamines by physiologically based kinetic modelling
2026
·
Spänig, Max
, Vogel, Matthias
, et al.
·
Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Extrapolation of in vitro effect concentrations to in vivo bioavailable concentrations using PBK modelling in humans for two classes of persistent and mobile compounds: triazoles and triazines
2026
·
Ravi Shankar, Abishek Laxmanan
, Irwan, Jenny
, et al.
·
Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Applicability of next-generation risk assessment generic PBK models and their performance within the chemical domain
2026
·
Spänig, Max
, Ashraf, Muhammad Waqar
, et al.
·
Fraunhofer-Publica (Fraunhofer-Gesellschaft)
S14-04 Integrate NAM data into bottom-up PBK modelling approaches
2025
·
M. Spänig
·
Toxicology Letters
P03-11 Assessing kinetic properties in food and feed: tebuconazole case study
2024
·
C. Drake
, M. Spänig
, et al.
·
Toxicology Letters
P03-12 Physiologically based kinetic modelling (PBK) using QIVIVE to predict the toxicokinetic profiles of triazoles via oral route of administration
2024
·
A.L. Ravi Shankar
, J. Irwan
, et al.
·
Toxicology Letters
P06-37: Uncertainty and sensitivity analysis of aggregated exposure PBK modelling with gaseous NMP
2023
·
M. Spänig
, S. Hahn
, et al.
·
Toxicology Letters
Show more works
View as search
Works count:
15
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type